- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Britain OKs Hybrids, Won't Fund Them
13 January 2009 3:57 pm
The stem cell community is stirred up with the news that after all the trouble U.K. scientists went to to persuade the government to let them make "hybrid" embryos, they can't get funding to do the work. The technique offers a potential way to generate genetically tailored cells without destroying human embryos. Three groups got licenses last year to cultivate embryos by inserting human DNA into animal eggs. Last fall, two of them failed to get funding for the work. The third group hasn't applied yet (subscription required).
From The Independent:
People reviewing grants may be looking at this from a completely different moral perspective and how much that has influenced people's perception about whether this should be funded, we don't know," said Professor Stephen Minger of King's College London.
Minger (pictured) told Science, however, that he thinks the "very competitive funding environment" led to the decision by the Medical Research Council reviewers. He also points out that his group would have needed £100,000, a major investment for the U.K. government, just for equipment.